12/2008-Present
Phase IV Study of Humira Safety for the Treatment of Plaque Psoriasis (ESPRIT Registry)
05/2009-Present
Phase III Study, Open-label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects who Completed a Preceding Psoriasis Study with ABT-874
09/2009-Present Double-Blind, Randomized, Phase III, Parallel Group Study Evaluating the Efficacy and Safety of CIP-Isotretinoin in Patients with Severe Recalcitrant Nodular Acne
10/2007-12/2007 Novum Phase III Study of Brand vs Generic Benzaclin Gel Efficacy and Safety
1/2008-10/2008 Novum Phase III Study of Brand vs. Generic Duac Gel Efficacy and Safety
3/2008-2/2009 Genentech Phase III Study of Raptiva Effectiveness for Scalp Psoriasis
8/2007-3/2008 Genentech Phase III Study of Raptiva in TNF- Alpha Biologic Failures
3/2006 – 08/2006
COBRA Trial, Phase IV Trial of Clobex Spray for the Treatment of Plaque Psoriasis
05/2009- 11/2009
Phase IV Study, Open-label, 12-week Trial Assessment of Effectiveness, Safety, and Subject Satisfaction with Oracea (doxycycline, USP) Capsules 40 mg (30mg immediate release and 10 mg delayed release beads) as Monotherapy or as Add-on Therapy to Existing Topical Regimens for the Treatment of Rosacea
6/2006-12/2009
Phase IV Study of Raptiva Safety (RESPONSE)
2/2009- 9/2009 Phase III Study of Brand vs. Generic Aldara Cream for the Treatment of Actinic Keratosis Efficacy and Safety
08/2009-6/2010 A 12 Month, Long-Term, Follow-up Study of Patients with Actinic Keratosis on the Head (face or scalp) who have completed Day 57 in Studies PEP005-016 or PEP005-025
12/2008- 6/2009
Phase III Study of ABT-874 vs Etanercept vs Placebo for the Treatment of Moderate to Severe Plaque Psoriasis Efficacy and Safety
